Are you Dr. Krishnan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
A.I. Dupont Hospital For Children
1600 Rockland Road
Wilmington, DE 19803Phone+1 302-651-4000Fax+1 302-651-4945
Summary
- Dr. Suba Krishnan, MD is a pediatric hematologist/oncologist in Wilmington, Delaware. She is currently licensed to practice medicine in Pennsylvania. She is affiliated with Thomas Jefferson University Hospital.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1996 - 1999
- Children's Hospital of MichiganResidency, Pediatrics, 1993 - 1996
- ArMed Forces Medical College PuneClass of 1986
Certifications & Licensure
- PA State Medical License 2007 - 2012
Publications & Presentations
PubMed
- 61 citationsTreatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial.David A. Reardon, Tae Min Kim, Jean-Sebastien Frenel, Matteo Simonelli, Juanita Lopez
Cancer. 2021-05-15 - 302 citationsEfficacy and Safety of Pembrolizumab for the Treatment of Advanced Biliary Cancer: Results From the KEYNOTE-158 and KEYNOTE-028 StudiesSarina Anne Piha-Paul, Do Youn Oh, Makoto Ueno, David Malka, Hyun Cheol Chung
International Journal of Cancer. 2020-10-15 - 224 citationsPembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies.Hyun Cheol Chung, Sarina Anne Piha-Paul, Jose A. Lopez-Martin, Jan H.M. Schellens, Steven Kao
Journal of Thoracic Oncology. 2020-04-01
Press Mentions
- Jeffrey Hatfield Takes over from Diego Miralles as CEO of Vividion; Dragonfly Scores a New Exec with COO Alex LugovskoyNovember 25th, 2020
- Mereo BioPharma Appoints Suba Krishnan, M.D. As Senior Vice President of Clinical DevelopmentNovember 23rd, 2020